Director

Robert J. Alpern, M.D.

Director·Abbott Laboratories

About

Dr. Robert J. Alpern serves as a director of Abbott Laboratories. He is not standing for re-election at the 2026 Annual Meeting and will continue to serve as a director until that meeting.

Also at Abbott Laboratories

NM Nita Ahuja, M.D. Director CB Claire Babineaux-Fontenot Director SP Sally E. Blount, Ph.D. Director RF Robert B. Ford Chairman of the Board and Chief Executive Officer; Director PG Paola Gonzalez Director MK Michelle A. Kumbier Director

Roles

Organization Role Dates Details
Abbott Laboratories Director Present Current role
Yale School of Medicine Dean 2004 to present
The University of Texas Southwestern Medical Center Dean July 1998 to June 2004
The University of Texas Southwestern Medical Center Associate Professor and Chief of the Division of Nephrology 1987 onward Also served as Professor of Internal Medicine and held the Ruth W. and Milton P. Levy, Sr. Chair in Molecular Nephrology and the Atticus James Gill, M.D. Chair in Medical Science.

External roles

Organization Role Dates
Yale New Haven Hospital Board of Directors member October 2005 to January 2020
Relypsa Scientific Advisory Board member 2007 onward
Ilypsa Scientific Advisory Board member 2004 to 2007

Related

Company Abbott Laboratories Company hub Person Nita Ahuja, M.D. Director Person Claire Babineaux-Fontenot Director Person Sally E. Blount, Ph.D. Director Person Robert B. Ford Chairman of the Board and Chief Executive Officer; Director Person Paola Gonzalez Director Person Michelle A. Kumbier Director Person Darren W. McDew Director Person Nancy McKinstry Lead Independent Director Person Michael G. O'Grady Director Person Michael F. Roman Director Person Daniel J. Starks Director Person John G. Stratton Director Deal Abbott Laboratories Advanced Medical Optics 2009 Deal page Deal Abbott Laboratories Alere 2017 Deal page Deal Abbott Laboratories Basf S Pharmaceutical Business Knoll 2001 Deal page
Source: Abbott Laboratories SEC filings and official company website

Where the filing does not disclose a value, this page states "Not disclosed" rather than estimating. Smaller filers are exempt from disclosing metric targets and achievement, and larger filers may omit forward targets for competitive reasons.

See how VectorShift works for your firm

Request Demo